Patents by Inventor Jonathan Viau
Jonathan Viau has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11780907Abstract: The present invention provides monoclonal antibodies, or antigen-binding fragments thereof, that bind to the influenza hemagglutinin (HA) protein, pharmaceutical compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for inhibiting or neutralizing influenza virus activity, thus providing a means of treating or preventing influenza infection in humans. In some embodiments, the invention provides for use of one or more antibodies that bind to the influenza HA for preventing viral attachment and/or entry into host cells. The antibodies of the invention may be used prophylactically or therapeutically and may be used alone or in combination with one or more other anti-viral agents or vaccines.Type: GrantFiled: January 24, 2019Date of Patent: October 10, 2023Assignee: REGENERON PHARMACEUTICALS, INC.Inventors: Lisa A. Purcell, Jonathan Viau, William Olson
-
Patent number: 11453714Abstract: The present invention provides monoclonal antibodies, or antigen-binding fragments thereof, that bind to the influenza hemagglutinin (HA) protein, pharmaceutical compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for inhibiting or neutralizing influenza virus activity, thus providing a means of treating or preventing influenza infection in humans. In some embodiments, the invention provides for use of one or more antibodies that bind to the influenza HA for preventing viral attachment and/or entry into host cells. The antibodies of the invention may be used prophylactically or therapeutically and may be used alone or in combination with one or more other anti-viral agents or vaccines.Type: GrantFiled: May 8, 2020Date of Patent: September 27, 2022Assignee: REGENERON PHARMACEUTICALS, INC.Inventors: Lisa A. Purcell, Jonathan Viau, William Olson
-
Publication number: 20210371505Abstract: The present invention provides monoclonal antibodies, or antigen-binding fragments thereof, that bind to the influenza hemagglutinin (HA) protein, pharmaceutical compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for inhibiting or neutralizing influenza virus activity, thus providing a means of treating or preventing influenza infection in humans. In some embodiments, the invention provides for use of one or more antibodies that bind to the influenza HA for preventing viral attachment and/or entry into host cells. The antibodies of the invention may be used prophylactically or therapeutically and may be used alone or in combination with one or more other anti-viral agents or vaccines.Type: ApplicationFiled: January 24, 2019Publication date: December 2, 2021Inventors: Lisa A. PURCELL, Jonathan VIAU, William OLSON
-
Publication number: 20200377575Abstract: The present invention provides monoclonal antibodies, or antigen-binding fragments thereof, that bind to the influenza hemagglutinin (HA) protein, pharmaceutical compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for inhibiting or neutralizing influenza virus activity, thus providing a means of treating or preventing influenza infection in humans. In some embodiments, the invention provides for use of one or more antibodies that bind to the influenza HA for preventing viral attachment and/or entry into host cells. The antibodies of the invention may be used prophylactically or therapeutically and may be used alone or in combination with one or more other anti-viral agents or vaccines.Type: ApplicationFiled: May 8, 2020Publication date: December 3, 2020Inventors: Lisa A. Purcell, Jonathan Viau, William Olson
-
Patent number: 10689436Abstract: The present invention provides monoclonal antibodies, or antigen-binding fragments thereof, that bind to the influenza hemagglutinin (HA) protein, pharmaceutical compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for inhibiting or neutralizing influenza virus activity, thus providing a means of treating or preventing influenza infection in humans. In some embodiments, the invention provides for use of one or more antibodies that bind to the influenza HA for preventing viral attachment and/or entry into host cells. The antibodies of the invention may be used prophylactically or therapeutically and may be used alone or in combination with one or more other anti-viral agents or vaccines.Type: GrantFiled: July 25, 2019Date of Patent: June 23, 2020Assignee: REGENERON PHARMACEUTICALS, INC.Inventors: Lisa A. Purcell, Jonathan Viau, William Olson
-
Publication number: 20200017576Abstract: The present invention provides monoclonal antibodies, or antigen-binding fragments thereof, that bind to the influenza hemagglutinin (HA) protein, pharmaceutical compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for inhibiting or neutralizing influenza virus activity, thus providing a means of treating or preventing influenza infection in humans. In some embodiments, the invention provides for use of one or more antibodies that bind to the influenza HA for preventing viral attachment and/or entry into host cells. The antibodies of the invention may be used prophylactically or therapeutically and may be used alone or in combination with one or more other anti-viral agents or vaccines.Type: ApplicationFiled: July 25, 2019Publication date: January 16, 2020Inventors: Lisa A. Purcell, Jonathan Viau, William Olson
-
Patent number: 10392432Abstract: The present invention provides monoclonal antibodies, or antigen-binding fragments thereof, that bind to the influenza hemagglutinin (HA) protein, pharmaceutical compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for inhibiting or neutralizing influenza virus activity, thus providing a means of treating or preventing influenza infection in humans. In some embodiments, the invention provides for use of one or more antibodies that bind to the influenza HA for preventing viral attachment and/or entry into host cells. The antibodies of the invention may be used prophylactically or therapeutically and may be used alone or in combination with one or more other anti-viral agents or vaccines.Type: GrantFiled: December 18, 2015Date of Patent: August 27, 2019Assignee: REGENERON PHARMACEUTICALS, INC.Inventors: Lisa A. Purcell, Jonathan Viau, William Olson
-
Patent number: 9396088Abstract: Example systems and methods of providing an indicator of execution progress of a computer task are presented. In one example, a command to perform a computer task is received. The command is compared to a log of commands for computer tasks previously performed on the computer system and their associated execution times. At least one execution time is retrieved from the log based on the comparison. An indicator indicating an estimated execution time for the computer task is provided for presentation to a user of the computer system based on the at least one retrieved execution time.Type: GrantFiled: March 8, 2013Date of Patent: July 19, 2016Assignee: SAP SEInventors: Xuebo Liang, Vincent Lavoie, Wanling Zhang, Alain Gauthier, Roman Sauber, Jonathan Viau
-
Publication number: 20160176953Abstract: The present invention provides monoclonal antibodies, or antigen-binding fragments thereof, that bind to the influenza hemagglutinin (HA) protein, pharmaceutical compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for inhibiting or neutralizing influenza virus activity, thus providing a means of treating or preventing influenza infection in humans. In some embodiments, the invention provides for use of one or more antibodies that bind to the influenza HA for preventing viral attachment and/or entry into host cells. The antibodies of the invention may be used prophylactically or therapeutically and may be used alone or in combination with one or more other anti-viral agents or vaccines.Type: ApplicationFiled: December 18, 2015Publication date: June 23, 2016Inventors: Lisa A. Purcell Ngambo, Jonathan Viau, William Olson
-
Publication number: 20150379585Abstract: A system, a method, a device, and a computer program product for single sheet planning of business objects are provided. A trade promotion data relating to at least one product is generated. Based on the generated trade promotion data, data stored in a database is queried. The data relates to at least one parameter associated with the generated trade promotion data.Type: ApplicationFiled: June 30, 2014Publication date: December 31, 2015Inventors: Joerg Hendricks, Michel Martin, Edward Palmer, Rischa Poncik, Roman Sauber, Jean-Luc Terree, Isabelle Thore, Jonathan Viau
-
Publication number: 20140258910Abstract: Example systems and methods of providing an indicator of execution progress of a computer task are presented. In one example, a command to perform a computer task is received. The command is compared to a log of commands for computer tasks previously performed on the computer system and their associated execution times. At least one execution time is retrieved from the log based on the comparison. An indicator indicating an estimated execution time for the computer task is provided for presentation to a user of the computer system based on the at least one retrieved execution time.Type: ApplicationFiled: March 8, 2013Publication date: September 11, 2014Applicant: SAP AGInventors: Xuebo Liang, Vincent Lavoie, Wanling Zhang, Alain Gauthier, Roman Sauber, Jonathan Viau
-
Publication number: 20100161397Abstract: Among other disclosed subject matter, a computer program product is tangibly embodied in a computer-readable storage medium and includes instructions that when executed by a processor perform a method for facilitating customer recycling of a mobile device. The method includes receiving an input in a mobile device from a user, the input initiating execution of program code configured to automatically present the user up-to-date instructions on how to recycle the mobile device. The method includes presenting, in response to the input, the up-to-date instructions on a display of the mobile device.Type: ApplicationFiled: December 24, 2008Publication date: June 24, 2010Applicant: SAP AGInventors: Alain Gauthier, Cesar Chirino, Hariharan Arumugam, Jonathan Viau, Marc Bernard, Subramaniam Raman